Follow-Up MRI for Small Brain AVMs Treated by Radiosurgery: Is Gadolinium Really Necessary?


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
03 2020
Historique:
received: 26 09 2019
accepted: 17 12 2019
pubmed: 8 2 2020
medline: 21 10 2020
entrez: 8 2 2020
Statut: ppublish

Résumé

Follow-up MR imaging of brain AVMs currently relies on contrast-enhanced sequences. Noncontrast techniques, including arterial spin-labeling and TOF, may have value in detecting a residual nidus after radiosurgery. The aim of this study was to compare noncontrast with contrast-enhanced MR imaging for the differentiation of residual-versus-obliterated brain AVMs in radiosurgically treated patients. Twenty-eight consecutive patients with small brain AVMs (<20 mm) treated by radiosurgery were followed with the same MR imaging protocol. Three neuroradiologists, blinded to the results, independently reviewed the following: 1) postcontrast images alone (4D contrast-enhanced MRA and postcontrast 3D T1 gradient recalled-echo), 2) arterial spin-labeling and TOF images alone, and 3) all MR images combined. The primary end point was the detection of residual brain AVMs using a 5-point scale, with DSA as the reference standard. The highest interobserver agreement was for arterial spin-labeling/TOF (κ = 0.81; 95% confidence interval, 0.66-0.93). Regarding brain AVM detection, arterial spin-labeling/TOF had higher sensitivity (sensitivity, 85%; specificity, 100%; 95% CI, 62-97) than contrast-enhanced MR imaging (sensitivity, 55%; specificity, 100%; 95% CI, 27-73) and all MR images combined (sensitivity, 75%; specificity, 100%; 95% CI, 51-91) ( In this study of radiosurgically treated patients with small brain AVMs, arterial spin-labeling/TOF was found to be superior to gadolinium-enhanced MR imaging in detecting residual AVMs.

Sections du résumé

BACKGROUND AND PURPOSE
Follow-up MR imaging of brain AVMs currently relies on contrast-enhanced sequences. Noncontrast techniques, including arterial spin-labeling and TOF, may have value in detecting a residual nidus after radiosurgery. The aim of this study was to compare noncontrast with contrast-enhanced MR imaging for the differentiation of residual-versus-obliterated brain AVMs in radiosurgically treated patients.
MATERIALS AND METHODS
Twenty-eight consecutive patients with small brain AVMs (<20 mm) treated by radiosurgery were followed with the same MR imaging protocol. Three neuroradiologists, blinded to the results, independently reviewed the following: 1) postcontrast images alone (4D contrast-enhanced MRA and postcontrast 3D T1 gradient recalled-echo), 2) arterial spin-labeling and TOF images alone, and 3) all MR images combined. The primary end point was the detection of residual brain AVMs using a 5-point scale, with DSA as the reference standard.
RESULTS
The highest interobserver agreement was for arterial spin-labeling/TOF (κ = 0.81; 95% confidence interval, 0.66-0.93). Regarding brain AVM detection, arterial spin-labeling/TOF had higher sensitivity (sensitivity, 85%; specificity, 100%; 95% CI, 62-97) than contrast-enhanced MR imaging (sensitivity, 55%; specificity, 100%; 95% CI, 27-73) and all MR images combined (sensitivity, 75%; specificity, 100%; 95% CI, 51-91) (
CONCLUSIONS
In this study of radiosurgically treated patients with small brain AVMs, arterial spin-labeling/TOF was found to be superior to gadolinium-enhanced MR imaging in detecting residual AVMs.

Identifiants

pubmed: 32029465
pii: ajnr.A6404
doi: 10.3174/ajnr.A6404
pmc: PMC7077895
doi:

Substances chimiques

Spin Labels 0
Gadolinium AU0V1LM3JT

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

437-445

Informations de copyright

© 2020 by American Journal of Neuroradiology.

Références

Mymensingh Med J. 2015 Apr;24(2):356-65
pubmed: 26007266
AJNR Am J Neuroradiol. 2012 Jan;33(1):61-8
pubmed: 22158927
Korean J Radiol. 2019 Jan;20(1):134-147
pubmed: 30627029
AJNR Am J Neuroradiol. 2012 Feb;33(2):232-8
pubmed: 22095967
Radiology. 2003 May;227(2):522-8
pubmed: 12637677
AJNR Am J Neuroradiol. 2015 Oct;36(10):1859-65
pubmed: 26294649
Radiology. 2008 Jan;246(1):205-13
pubmed: 17951352
AJNR Am J Neuroradiol. 2017 Jan;38(1):71-76
pubmed: 27789452
IEEE Trans Med Imaging. 2015 Jun;34(6):1392-402
pubmed: 25616010
Acta Neurochir (Wien). 2016 Sep;158(9):1683-90
pubmed: 27368701
Br J Neurosurg. 2017 Dec;31(6):641-647
pubmed: 28830253
JAMA. 2011 Nov 9;306(18):2011-9
pubmed: 22068993
J Neurosurg Sci. 2018 Aug;62(4):490-504
pubmed: 29582976
Radiology. 2016 Nov;281(2):337-356
pubmed: 27755938
Neuroradiology. 2015 Dec;57(12):1181-202
pubmed: 26351201
AJNR Am J Neuroradiol. 2014 Oct;35(10):1903-9
pubmed: 24904052
J Neuroradiol. 2020 Feb;47(1):13-19
pubmed: 30658138
N Engl J Med. 1999 Jun 10;340(23):1812-8
pubmed: 10362826
Neurol Res. 2011 Oct;33(8):803-19
pubmed: 22004703
AJNR Am J Neuroradiol. 2018 Apr;39(4):669-677
pubmed: 29545245
J Neurosurg. 2007 Nov;107(5):965-72
pubmed: 17977268
AJNR Am J Neuroradiol. 2008 Apr;29(4):681-7
pubmed: 18397967
Neurosurg Clin N Am. 2012 Jan;23(1):1-6
pubmed: 22107853

Auteurs

X Leclerc (X)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France xavier.leclerc@chru-lille.fr.
Inserm U1171, Degenerative and Vascular Cognitive Disorders (X.L., O.O., J.-P.P., G.K.), University of Lille, Lille, France.

O Guillaud (O)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.

N Reyns (N)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.
Inserm U1189-ONCO-THAI-Image Assisted Laser Therapy for Oncology (N. Reyns), University of Lille, Lille, France.

J Hodel (J)

Department of Neuroradiology (J.H.), Hôpital Henri Mondor, Créteil, France; EA 2694-Public Health: Epidemiology and Quality of Care (N. Ramdane), University of Lille, Centre Hospitalier Universitaire Lille, Lille, France.

O Outteryck (O)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.
Inserm U1171, Degenerative and Vascular Cognitive Disorders (X.L., O.O., J.-P.P., G.K.), University of Lille, Lille, France.

F Bala (F)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.

N Bricout (N)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.

M Bretzner (M)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.

N Ramdane (N)

Department of Neuroradiology (J.H.), Hôpital Henri Mondor, Créteil, France; EA 2694-Public Health: Epidemiology and Quality of Care (N. Ramdane), University of Lille, Centre Hospitalier Universitaire Lille, Lille, France.

J-P Pruvo (JP)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.
Inserm U1171, Degenerative and Vascular Cognitive Disorders (X.L., O.O., J.-P.P., G.K.), University of Lille, Lille, France.

L Hacein-Bey (L)

Neuroradiology, Radiology Department (L.H.-B.), University of California Davis School of Medicine, Sacramento, California.

G Kuchcinski (G)

From the Departments of Neuroradiology (X.L., O.G., O.O., F.B., N.B., M.B., J.-P.P., G.K.), Neurosurgery (N. Reyns), Neurology (O.O.), Centre Hospitalier Universitaire Lille, Lille, France.
Inserm U1171, Degenerative and Vascular Cognitive Disorders (X.L., O.O., J.-P.P., G.K.), University of Lille, Lille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH